Golimumab Administered Subcutaneously Every 4 Wks in Patients with Active Rheumatoid Arthritis Despite Methotrexate: Wk 24 Results of the Randomized, Double-Blind, Placebo-Controlled, GO-FORWARD Study

  • 배상철
제목
Golimumab Administered Subcutaneously Every 4 Wks in Patients with Active Rheumatoid Arthritis Despite Methotrexate: Wk 24 Results of the Randomized, Double-Blind, Placebo-Controlled, GO-FORWARD Study
저자
배상철
발행일
2008-10-24
학회명
The 72th ACR meeting
개최지
San Francisco